AIML Subsidiary NeuralCloud Solutions and Heartdent Center Ltd. Launch Pilot Project to Advance Cardiac Care in Jamaica
AIML (OTCQB:AIMLF) announced on October 15, 2025 that its subsidiary NeuralCloud Solutions is launching a pilot of CardioYield with Heartdent Center in Kingston, Jamaica.
The feasibility study will pair a single-lead ECG wearable chest strap with CardioYield's AI Holter-reporting and ECG analysis to test workflow integration, operational impact, and a low-cost, scalable diagnostic model aimed at expanding access to cardiac care in Jamaica.
The pilot seeks to validate clinical workflow, improve affordability and reduce wait times for diagnostics in a country where cardiovascular disease accounts for about one-third of deaths.
AIML (OTCQB:AIMLF) ha annunciato il 15 ottobre 2025 che la sua controllata NeuralCloud Solutions sta lanciando una fase pilota di CardioYield con Heartdent Center a Kingston, Jamaica.
Lo studio di fattibilità abbinerà una fascia toracica ECG a singolo polo con ECG wearable e l'analisi Holter IA e ECG di CardioYield per testare l'integrazione del flusso di lavoro, l'impatto operativo e un modello diagnostico a basso costo e scalabile volto ad espandere l'accesso alle cure cardiache in Giamaica.
Il pilota mira a convalidare il flusso di lavoro clinico, a migliorare l'accessibilità economica e a ridurre i tempi d'attesa per le diagnostiche in un paese in cui le malattie cardiovascolari rappresentano circa un terzo delle morti.
AIML (OTCQB:AIMLF) anunció el 15 de octubre de 2025 que su subsidiaria NeuralCloud Solutions está lanzando un piloto de CardioYield con Heartdent Center en Kingston, Jamaica.
El estudio de viabilidad combinará una correa de pecho con ECG de un solo canal con el informe Holter impulsado por IA y el análisis de ECG de CardioYield para probar la integración del flujo de trabajo, el impacto operativo y un modelo diagnóstico de bajo costo y escalable destinado a ampliar el acceso a la atención cardíaca en Jamaica.
El piloto busca validar el flujo de trabajo clínico, mejorar la asequibilidad y reducir los tiempos de espera para diagnósticos en un país en el que las enfermedades cardiovasculares representan aproximadamente un tercio de las muertes.
AIML (OTCQB:AIMLF)은 2025년 10월 15일에 자회사 NeuralCloud Solutions가 Kingston, Jamaica의 Heartdent Center와 함께 CardioYield 시범을 시작한다고 발표했다.
타당성 조사는 단일 리드 ECG 웨어러블 흉부 스트랩과 CardioYield의 AI Holter 보고 및 ECG 분석을 결합하여 워크플로우 통합, 운영 영향 및 저비용의 확장 가능한 진단 모델을 테스트하고 자메이카의 심장 관리 접근성을 확장하는 것을 목표로 한다.
시범은 임상 워크플로를 검증하고 진단의 비용 부담을 줄이며 대기 시간을 줄이려는 목표를 갖고 있으며, 심혈관 질환이 사망 원인의 약 3분의 1을 차지하는 국가에서 이를 달성하려 한다.
AIML (OTCQB:AIMLF) a annoncé le 15 octobre 2025 que sa filiale NeuralCloud Solutions lance un pilote de CardioYield avec le Heartdent Center à Kingston, en Jamaïque.
L’étude de faisabilité associera une sangle thoracique ECG à simple dérivation avec rapport Holter et analyse ECG pilotés par IA de CardioYield afin de tester l’intégration du flux de travail, l’impact opérationnel et un modèle diagnostic peu coûteux et scalable visant à élargir l’accès aux soins cardiaques en Jamaïque.
Le pilote vise à valider le flux de travail clinique, à améliorer l’accessibilité financière et à réduire les délais pour les diagnostics dans un pays où les maladies cardiovasculaires représentent environ un tiers des décès.
AIML (OTCQB:AIMLF) gab am 15. Oktober 2025 bekannt, dass seine Tochtergesellschaft NeuralCloud Solutions eine Pilotphase von CardioYield mit Heartdent Center in Kingston, Jamaika, startet.
Die Machbarkeitsstudie wird eine Ein-Lead-ECG-Wearable-Brustband mit den AI Holter-Berichten und der ECG-Analyse von CardioYield kombinieren, um die Arbeitsabläufe, die operative Auswirkung und ein kostengünstiges, skalierbares Diagnostikmodell zu testen, das darauf abzielt, den Zugang zur Herzmedizin in Jamaika zu erweitern.
Der Pilot soll den klinischen Arbeitsablauf validieren, die Erschwinglichkeit verbessern und Wartezeiten für Diagnostik reduzieren in einem Land, in dem Herz-Kreislauf-Erkrankungen etwa ein Drittel der Todesfälle ausmachen.
AIML (OTCQB:AIMLF) أعلنت في 15 أكتوبر 2025 أن شركة NeuralCloud Solutions التابعة لها ستطلق تجربة تشغيلية لـ CardioYield مع Heartdent Center في Kingston، جامايكا.
سيجمع دراسَة الجدوى بين حزام صدر ECG بقياس إحدى القنوات مع تقارير هولتر المدعومة بالذكاء الاصطناعي وتحليل ECG من CardioYield لاختبار تكامل سير العمل، والأثر التشغيلي، ونموذج تشخيصي منخفض التكلفة وقابل للتوسع يهدف إلى توسيع الوصول إلى رعاية القلب في جامايكا.
تهدف التجربة إلى التحقق من سير العمل السريري، وتحسين إمكانية التحمل من حيث التكلفة وتقليل أوقات الانتظار من أجل التشخيصات في بلد يمثل فيه أمراض القلب والأوعية الدموية نحو ثلث الوفيات.
AIML (OTCQB:AIMLF) 宣布于 2025年10月15日 其子公司 NeuralCloud Solutions 将与 Kingston, Jamaica 的 Heartdent Center 一同启动 CardioYield 的试点。
可行性研究将把单导联心电图可穿戴胸带与 CardioYield 的 AI Holter 报告和 ECG 分析结合起来，以测试工作流程整合、运营影响以及一个低成本、可扩展的诊断模型，旨在扩大牙买加的心脏护理可及性。
该试点旨在验证临床工作流程、提高可负担性并缩短诊断等待时间，在一个心血管疾病约占死亡人数三分之一的国家尤为重要。
- None.
- None.
Pilot Study to Lay the Groundwork for Expansion Across Jamaica
Goal of the Collaboration is to Demonstrate the Ability to Deliver Affordable, Accurate, and Scalable Holter Diagnostics with CardioYield™
TORONTO, ON, AB / ACCESS Newswire / October 15, 2025 / AI/ML Innovations Inc. ("AIML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) is pleased to announce that its wholly owned subsidiary, NeuralCloud Solutions Inc. ("Neural Cloud"), in collaboration with Heartdent Center Ltd. ("Heartdent Center"), in Kingston, Jamaica, is launching a pilot program of CardioYield™, AIML's AI-powered Holter-reporting and ECG analysis platform. The Company thanks Jamaican Canadian business leader and investor Wayne Isaacs for making this introduction to the clinical cardiology professionals in Jamaica.
This feasibility study will evaluate CardioYield's workflow integration and operational impact within Heartdent Center's cardiology practice, creating a foundation for broader deployment. The pilot will combine a single lead ECG wearable chest strap with CardioYield™ software to deliver a low-cost, high-accuracy solution designed to expand access to cardiac care in Jamaica.
Cardiovascular disease is a leading cause of death in Jamaica, accounting for one-third of all mortality¹. Access to timely and affordable diagnostics is limited, with patients often facing high costs, device shortages, and long wait times. This pilot aims to demonstrate how AIML's platform can enable world-class cardiac care at scale.
Dr. Geordan Goire Guevara, Interventional Cardiologist, Founder and Medical Director of Heartdent Center, stated:
"Heartdent Center is committed to bringing the highest level of cardiac care to Jamaica. Partnering with AIML enables us to pilot innovative technologies that reduce costs and improve access, ensuring more Jamaicans can benefit from gold-standard diagnostics."
Esmat Naikyar, President of Neural Cloud and Chief Product Officer of AIML, said:
"This pilot marks an important step in extending CardioYield's impact beyond North America. By working with Heartdent Center, we can validate how our solution addresses real-world workflow challenges while delivering reliable, affordable Holter reporting for patients who need it most."
Paul Duffy, Executive Chairman and CEO of AIML, added:
"Jamaica faces an urgent need for scalable, cost-effective cardiac diagnostics. Our goal is to demonstrate how CardioYield, combined with single lead ECG wearable devices, can provide a full solution that sets a new standard of care."
Wayne Isaacs, Jamaican Canadian business leader and investor states:
"The integration of advanced digital health solutions like CardioYield can set new standards for patient-centered care and significantly improve patient outcomes by enabling timely and accurate diagnosis, facilitating continuous monitoring, and supporting more effective clinical interventions."
¹World Heart Federation. (n.d.). Heart health in Jamaica. World Heart Observatory. Retrieved October 10, 2025, from https://world-heart-federation.org/world-heart-observatory/countries/jamaica/
About Heartdent Center Ltd.
Heartdent Center Ltd., founded and directed by Dr. Geordan Goire Guevara, MD FACC, provides comprehensive cardiology services in Jamaica, including the assessment and management of all cardiovascular conditions, performance and interpretation of cardiac screening tests, and advanced interventional procedures such as device implantation and intracardiac interventions.
About AIML Innovations Inc.
https://www.aiml.health/
AIML Innovations Inc. is a global technology company pioneering the use of artificial intelligence and neural networks to transform digital health. Our proprietary platforms leverage advanced signal processing and deep learning to convert complex biometric data into actionable clinical insights-supporting earlier diagnosis, personalized treatment, and more effective care.
AIML's shares trade on the Canadian Securities Exchange (CSE:AIML), the OTCQB Venture Market (AIMLF), and the Frankfurt Stock Exchange (42FB).
For more information about AIML:
Please see AIML's website or the Company's filed documents at www.sedarplus.ca.
Contact:
Blake Fallis
(778) 405-0882
info@aiml.health
On behalf of the Board of Directors:
Paul Duffy, Executive Chairman and CEO
Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.
Forward Looking Statements - Certain information set forth in this news release may contain forward-looking statements that involve substantial known and unknown risks and uncertainties, including risks associated with the implementation of the Company's products and services. These forward-looking statements are subject to numerous risks and uncertainties, certain of which are beyond the control of the Company, including with respect to the nature and timing of future operations and the receipt of all applicable regulatory approvals. Readers are cautioned that the assumptions used in the preparation of such information, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements.
SOURCE: AI/ML Innovations, Inc.
View the original press release on ACCESS Newswire
FAQ
What is the AIMLF pilot with Heartdent Center in Jamaica announced on October 15, 2025?
How could the AIMLF CardioYield pilot affect access to cardiac diagnostics in Jamaica?
What technology will AIMLF use in the Jamaica pilot starting October 2025?
Who are the partners in the AIMLF CardioYield pilot in Kingston?
Will the AIMLF pilot in Jamaica produce clinical results or regulatory approvals?
How does AIMLF describe the need for the CardioYield pilot in Jamaica?
